# Seer

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/seer-2

- Industry: Biotechnology
- Headquarters: Redwood City, US
- Website: www.seer.bio
- Total disclosed funding: $164M
- Latest round: Series D (May 12, 2020)
- Investors on record: 9

## About

Based in California, US, and founded in 2017, Seer, Inc., formerly known as Seer Biosciences, Inc. operates as a biotechnology company that develops innovative solutions that act as a gateway to the proteome. The company was co-founded by Omid Farokhzad, M.D., its CEO, Philip Ma, Ph.D., and Robert Langer, Sc.D. In July 2020, Seer raised USD 55 million in venture funding led by new investor Fidelity Investments, with participation from HBM Partners, Emerson Collective, aMoon, and  Maverick Ventures. And in December 2020, Seer raised USD 175 million in an IPO, at USD 19 per share on the NASDAQ, and it has approximately 60 employees. 

The company's product, Proteograph™, includes optimized reagents and consumables, automation, and software. The product suite enables medical research to conduct unbiased proteomics analysis.

The company generates revenue by selling its Proteograph Product Suite for research. 

The company plans to launch its Proteograph™ suite of products in 2021.

## Funding rounds

- Series D, May 12, 2020, $55M — T Rowe Price, HBM Partners, Invus [DUP], Fidelity Investments, Maverick Capital, Emerson Collective, aMoon
- Series D, Dec 17, 2019, $55M — T Rowe Price, HBM Partners, aMoon
- Series C, Jul 17, 2019, $18M — AJU IB Investment, Invus [DUP], Maverick Capital, Wing
- Series B, Dec 17, 2018, $30M — Invus [DUP], Maverick Capital, Emerson Collective
- Series A, Dec 1, 2017, $6M — Maverick Capital

## Investors

- Maverick Capital (https://capitalatlas.ai/funds/maverick-capital) — Series A, Series B, Series C, Series D
- Invus [DUP] — Series B, Series C, Series D
- Emerson Collective — Series B, Series D
- AJU IB Investment (https://capitalatlas.ai/funds/aju-ib-investment) — Series C
- Wing (https://capitalatlas.ai/funds/wing) — Series C
- T Rowe Price (https://capitalatlas.ai/funds/t-rowe-price) — Series D
- HBM Partners (https://capitalatlas.ai/funds/hbm-partners) — Series D
- aMoon (https://capitalatlas.ai/funds/amoon) — Series D
- Fidelity Investments (https://capitalatlas.ai/funds/fidelity-investments) — Series D